Agape ATP (ATPC) Competitors

Exagen (NASDAQ:XGN) and Agape ATP (NASDAQ:ATPC) are both small-cap medical companies, but which is the superior investment? We will compare the two companies based on the strength of their dividends, media sentiment, valuation, earnings, institutional ownership, analyst recommendations, risk and profitability.

Is XGN or ATPC more profitable?

Exagen has a net margin of -28.85% compared to Agape ATP's net margin of -183.13%. Agape ATP's return on equity of -20.32% beat Exagen's return on equity.

Company	Net Margins	Return on Equity	Return on Assets
Exagen	-28.85%	-130.38%	-34.69%
Agape ATP	-183.13%	-20.32%	-18.55%

Do analysts rate XGN or ATPC?

Exagen currently has a consensus price target of $11.25, indicating a potential upside of 16.34%. Given Exagen's stronger consensus rating and higher probable upside, equities analysts clearly believe Exagen is more favorable than Agape ATP.

Company	Sell Ratings	Hold Ratings	Buy Ratings	Strong Buy Ratings	Rating Score
Exagen	0 Sell rating(s)	0 Hold rating(s)	7 Buy rating(s)	0 Strong Buy rating(s)	3.00
Agape ATP	0 Sell rating(s)	0 Hold rating(s)	0 Buy rating(s)	0 Strong Buy rating(s)	0.00

Does the media prefer XGN or ATPC?

In the previous week, Agape ATP had 1 more articles in the media than Exagen. MarketBeat recorded 3 mentions for Agape ATP and 2 mentions for Exagen. Exagen's average media sentiment score of 1.77 beat Agape ATP's score of 0.94 indicating that Exagen is being referred to more favorably in the media.

Company	Overall Sentiment
Exagen	Very Positive
Agape ATP	Positive

Do insiders & institutionals believe in XGN or ATPC?

75.3% of Exagen shares are owned by institutional investors. Comparatively, 0.0% of Agape ATP shares are owned by institutional investors. 12.6% of Exagen shares are owned by company insiders. Comparatively, 9.7% of Agape ATP shares are owned by company insiders. Strong institutional ownership is an indication that endowments, large money managers and hedge funds believe a company will outperform the market over the long term.

Which has more volatility & risk, XGN or ATPC?

Exagen has a beta of 1.6, meaning that its share price is 60% more volatile than the S&P 500. Comparatively, Agape ATP has a beta of -0.98, meaning that its share price is 198% less volatile than the S&P 500.

Which has higher valuation & earnings, XGN or ATPC?

Agape ATP has lower revenue, but higher earnings than Exagen. Exagen is trading at a lower price-to-earnings ratio than Agape ATP, indicating that it is currently the more affordable of the two stocks.

Company	Gross Revenue	Price/Sales Ratio	Net Income	Earnings Per Share	Price/Earnings Ratio
Exagen	$58.86M	3.61	-$15.11M	-$0.89	-10.87
Agape ATP	$1.32M	50.24	-$2.47M	-$0.41	-3.23

Summary

Exagen beats Agape ATP on 9 of the 16 factors compared between the two stocks.